Become a Member
Dark Mode
Become a Member
Naukri Crisis
Uncovering Hate
Maharashtra Election
Manipur Conflict
Climate Change
Members Only
WebQoof
My Report
Brand Studio
FIT
Gender
Opinion
Videos
Entertainment
Sports
World
Explainers
More
Podcasts
Politics
The Quint Lab
Graphic Novels
Law
Education
Members' Opinion
South Asians
NEON
Dark Mode
Become a Member
Home
Naukri Crisis
Uncovering Hate
Maharashtra Election
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
Covaxin Efficacy
Covaxin Has 77.8% Efficacy Against COVID: Phase 3 Data in the Lancet
Members Only
Covaxin Effective Against Delta Plus Covid Variant: ICMR Study
ADVERTISEMENT
REMOVE AD
Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel
'Covaxin Has 77.8% Efficacy in Phase 3': What Do We Know So Far?
Members Only
Covaxin COVID Vaccine 77.8% Effective; 10 Things to Know About the Phase 3 Data
Members Only
Covaxin Has 77.8% Efficacy Against COVID: Phase 3 Data in the Lancet
Covaxin Effective Against Delta Plus Covid Variant: ICMR Study
Decoding Covaxin's Final Phase 3 Trial Data With Dr Shahid Jameel
Members Only
Covaxin COVID Vaccine 77.8% Effective; 10 Things to Know About the Phase 3 Data
'Covaxin Has 77.8% Efficacy in Phase 3': What Do We Know So Far?
